Biopharmaceutical company
CY 2021 Home Health Prospective Payment System Rate Update/ Home Infusion Therapy Proposed Rule, CMS-1730-P RIN 0938-AU-06. Implementation of Sec. 50401 of H.R. 1892, the Bipartisan Budget Act of 2018. S. 551, the REFUND Act of 2019. S. 3129/H.R. 19, the Lower Costs, More Cures Act. Home administration of injectable and infusible drugs including CMS-1744-IFC and CMS-5531-IFC.
MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
JOHN MCMANUS (Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas) ALANNA TEMME (LD, Rep. Jon Porter)
Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas LD, Rep. Jon Porter